- Home
- ATNM vs NDLS Comparison
ATNM vs NDLS Comparison
Compare ATNM & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- NDLS
- Stock Information
- Founded
- ATNM 2000
- NDLS 1995
- Country
- ATNM United States
- NDLS United States
- Employees
- ATNM N/A
- NDLS N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- ATNM Health Care
- NDLS Consumer Discretionary
- Exchange
- ATNM Nasdaq
- NDLS Nasdaq
- Market Cap
- ATNM 56.5M
- NDLS 51.6M
- IPO Year
- ATNM N/A
- NDLS 2013
- Fundamental
- Price
- ATNM $1.73
- NDLS $1.16
- Analyst Decision
- ATNM Strong Buy
- NDLS Strong Buy
- Analyst Count
- ATNM 5
- NDLS 3
- Target Price
- ATNM $14.20
- NDLS $3.67
- AVG Volume (30 Days)
- ATNM 285.8K
- NDLS 141.3K
- Earning Date
- ATNM 10-31-2024
- NDLS 11-06-2024
- Dividend Yield
- ATNM N/A
- NDLS N/A
- EPS Growth
- ATNM N/A
- NDLS N/A
- EPS
- ATNM N/A
- NDLS N/A
- Revenue
- ATNM $81,000.00
- NDLS $500,920,000.00
- Revenue This Year
- ATNM $186.10
- NDLS $1.11
- Revenue Next Year
- ATNM $19,248.94
- NDLS $1.14
- P/E Ratio
- ATNM N/A
- NDLS N/A
- Revenue Growth
- ATNM 80.00
- NDLS N/A
- 52 Week Low
- ATNM $1.33
- NDLS $1.06
- 52 Week High
- ATNM $10.24
- NDLS $3.50
- Technical
- Relative Strength Index (RSI)
- ATNM 41.48
- NDLS 44.16
- Support Level
- ATNM $1.48
- NDLS $1.09
- Resistance Level
- ATNM $1.80
- NDLS $1.20
- Average True Range (ATR)
- ATNM 0.12
- NDLS 0.07
- MACD
- ATNM 0.04
- NDLS 0.02
- Stochastic Oscillator
- ATNM 54.44
- NDLS 63.33
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.